13F Data
13F filer · CIK 1511901

Broadfin Capital, LLC

New York, NY · filing since Q2 2013 · last filing Feb 14, 2020
Reported value
$746.8M
+$205.9M vs prior
Positions
40
New / sold out
12 / 16
Added / reduced
11 / 13
Turnover
34.4%
buys $305.0M · sells $221.2M
Top-10 weight
63.7%

Biggest buys vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
NewISHARES TRPUT+800,000–+$132.5M
NewSTAAR SURGICAL CO+462,118–+$16.3M
AddedALKERMES PLC+784,500+315.1%+$16.0M
AddedQUOTIENT LTD+1,380,754+225.1%+$13.1M
NewLANTHEUS HLDGS INC+617,953–+$12.7M
AddedNANOSTRING TECHNOLOGIES INC+444,800+401.4%+$12.4M
NewVAPOTHERM INC+1,003,099–+$12.2M
AddedVIEWRAY INC+2,573,005+85.7%+$10.9M
AddedLA JOLLA PHARMACEUTICAL CO+2,506,224+1378.2%+$9.8M
NewALEXION PHARMACEUTICALS INC+83,100–+$9.0M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q3 2019

ChangeSecurityShares changeChange %Est. trade value
ReducedSPDR SERIES TRUSTPUT-350,000-50.0%$-33.3M
ReducedIOVANCE BIOTHERAPEUTICS INC-597,800-52.9%$-16.5M
Sold outALLERGAN PLC-96,504-100.0%$-16.2M
ReducedAVADEL PHARMACEUTICALS PLC-2,073,661-66.8%$-15.7M
Sold outMIRATI THERAPEUTICS INCCALL-200,000-100.0%$-15.6M
Sold outNEVRO CORP-150,510-100.0%$-12.9M
Sold outWRIGHT MED GROUP N V-618,500-100.0%$-12.8M
Sold outABBVIE INC-154,500-100.0%$-11.7M
ReducedAMARIN CORP PLC-519,767-33.1%$-11.1M
Sold outGLOBAL BLOOD THERAPEUTICS IN-177,016-100.0%$-8.6M
19 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $511.2MQ3 2013: $563.3MQ4 2013: $758.2MQ1 2014: $1.0BQ2 2014: $2.0BQ3 2014: $953.8MQ4 2014: $1.2BQ1 2015: $1.3BQ2 2015: $1.9BQ3 2015: $1.8BQ4 2015: $1.6BQ1 2016: $1.0BQ2 2016: $1.0BQ3 2016: $1.1BQ4 2016: $900.7MQ1 2017: $825.6MQ2 2017: $823.2MQ3 2017: $676.0MQ4 2017: $611.8MQ1 2018: $641.7MQ2 2018: $635.2MQ3 2018: $679.5MQ4 2018: $760.5MQ1 2019: $484.3MQ2 2019: $459.6MQ3 2019: $540.9MQ4 2019: $746.8M
Q2 2013Q4 2019

Holdings · Q4 2019

#SecuritySharesValueWeight
1SPYSPDR S&P 500 ETF TRPUT440,000$141.6M18.96%
2ISHARES TRPUTRUSSELL 2000 ETF800,000$132.5M17.75%
3SPDR SERIES TRUSTPUTS&P BIOTECH350,000$33.3M4.46%
4BIOHAVEN PHARMACTL HLDG CO LCALLCOM600,000$32.7M4.37%
5BIODELIVERY SCIENCES INTL INCOM4,300,066$27.2M3.64%
6VIEWRAY INCCOM5,574,366$23.5M3.15%
7AMARIN CORP PLCSPONS ADR NEW1,049,244$22.5M3.01%
8BIOHAVEN PHARMACTL HLDG CO LCOM409,338$22.3M2.98%
9ALKERMES PLCSHS1,033,500$21.1M2.82%
10QUOTIENT LTDSHS1,994,183$19.0M2.54%
30 more rows. Subscribe for $29/month to see every row, download the data and use the API.